Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Read

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2020
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage StudyHeather Valerio, Maryam Alavi, David Silk, et al.
American Journal of Preventive Medicine|June 22, 2015
Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three PopulationsKirsty S Smith, Jane S Hocking, Marcus Y Chen, et al.
Drug and Alcohol Review|December 5, 2025
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on OpioidsM J Stowe, Anna Conway, Frederick L Altice, et al.
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Drug and Alcohol Review|November 28, 2019
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectivesNicholas Lintzeris, Lauren A Monds, Maria Bravo, et al.
The Lancet Regional Health. Western Pacific|September 12, 2024
Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022Michael W Traeger, Rebecca Guy, Caroline Taunton, et al.
Journal of Viral Hepatitis|November 8, 2019
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife studySahar Bajis, Jason Grebely, Behzad Hajarizadeh, et al.
Sexual Health|February 19, 2024
Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018-2022Stephanie C Munari, Anna L Wilkinson, Jason Asselin, et al.
The International Journal on Drug Policy|May 9, 2022
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage studyHeather Valerio, Maryam Alavi, Anna Conway, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2020
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage StudyHeather Valerio, Maryam Alavi, David Silk, et al.
American Journal of Preventive Medicine|June 22, 2015
Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three PopulationsKirsty S Smith, Jane S Hocking, Marcus Y Chen, et al.
Drug and Alcohol Review|December 5, 2025
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on OpioidsM J Stowe, Anna Conway, Frederick L Altice, et al.
Health Science Reports|August 24, 2022
Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohortSofia R Bartlett, Andrey Verich, Joanne Carson, et al.
Drug and Alcohol Review|November 28, 2019
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectivesNicholas Lintzeris, Lauren A Monds, Maria Bravo, et al.
The Lancet Regional Health. Western Pacific|September 12, 2024
Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022Michael W Traeger, Rebecca Guy, Caroline Taunton, et al.
Journal of Viral Hepatitis|November 8, 2019
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife studySahar Bajis, Jason Grebely, Behzad Hajarizadeh, et al.
Sexual Health|February 19, 2024
Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018-2022Stephanie C Munari, Anna L Wilkinson, Jason Asselin, et al.
The International Journal on Drug Policy|May 9, 2022
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage studyHeather Valerio, Maryam Alavi, Anna Conway, et al.
Pageof 9